Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Ambulatory Oxygen
United Therapeutics Europe Ltd
Lung; Disease, Fibroid (Chronic)
1 trial -
Amodiaquine plus Artesunate co-administration
United Therapeutics Europe Ltd
Malaria
1 trial -
Anti-hypertensive therapy
Arrowhead Pharmaceuticals Ireland Limited
Hypertension
1 trial -
Antiepileptic drug therapy
United Therapeutics Europe Ltd
Epilepsy
1 trial -
Antiretroviral therapy (ART)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Aripiprazole
United Therapeutics Europe Ltd
Hyperprolactinemia
1 trial -
Arm A: ABC+3TC+NNRTI
United Therapeutics Europe Ltd
Human Immunodeficiency Virus
1 trial -
Artemether-lumefantrine combination
United Therapeutics Europe Ltd
Plasmodium Vivax Infection
1 trial -
Artesunate-amodiaquine combination
United Therapeutics Europe Ltd
Malaria,Falciparum
1 trial -
Atomoxetine hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Disorder With Hyperactivity
1 trial -
Atorvastatin
United Therapeutics Europe Ltd
Major Coronary Event
1 trial -
Atorvastatin 20mg
United Therapeutics Europe Ltd
Cardiovascular Disease
1 trial -
Azithromycin
United Therapeutics Europe Ltd
Typhoid Fever
1 trial -
Azithromycin Pill
United Therapeutics Europe Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
2 trials -
Bempedoic Acid / Ezetimibe Oral Tablet
Esperion Therapeutics
Cardiovascular Diseases
1 trial -
Bempedoic Acid 180 MG Oral Tablet
Esperion Therapeutics
Healthy Lactating Women
1 trial -
Betadine bucal 100 mg/ml solución bucal, Agua oxigenada Foret 3 % solución cutánea y concentrado para solución bucal, Agua para preparaciones inyectables Meinsol, disolvente para uso parenteral
The George Institute
Respiratory diseases
1 trial -
Biomarker
United Therapeutics Europe Ltd
Transplantation, Liver
1 trial -
Botulinum Toxin A
United Therapeutics Europe Ltd
Low Back Pain
1 trial -
Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe
LEO Pharma A/S
Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.
1 trial -
Brolucizumab
The University of Hong Kong
Age-Related Macular Degeneration
1 trial -
Bubble-Enhanced FAST (BEFAST)
United Therapeutics Europe Ltd
Abdominal Trauma
1 trial -
Bupivacaine
United Therapeutics Europe Ltd
Amputation Stumps
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources